Bausch + Lomb Corporation (BLCO)

Market Cap	7.03B
Revenue (ttm)	4.50B
Net Income (ttm)	-456.00M
Shares Out	352.05M
EPS (ttm)	-1.30
PE Ratio	n/a
Forward PE	24.47
Dividend	n/a
Ex-Dividend Date	n/a

Volume	616,222
Open	19.96
Previous Close	20.00
Day's Range	19.67 - 20.10
52-Week Range	13.16 - 21.00
Beta	0.46
Analysts	Buy
Price Target	18.50 (-7.31%)
Earnings Date	Oct 30, 2024

About BLCO

Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, South Korea, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products comprising over-the-counter eye drops, eye vitamins, and ...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: May 6, 2022
• Employees: 13,300
• Stock Exchange: NYSE
• Ticker Symbol: BLCO
• Website: https://www.bausch.com

Analyst Forecast

According to 10 analysts, the average rating for BLCO stock is "Buy." The 12-month stock price forecast is $18.5, which is a decrease of -7.31% from the latest price.

Price Target

$18.5

(-7.31% downside)

Analyst Consensus: Buy